跳到正文

Davidson Matt 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Davidson Matt(CIK 1741937)在 2 家公司共报告 8 笔 SEC Form 4 内部人交易(最近一笔 2026-11-04)。

日期公司身份类型股数市值
2026-11-04Azora Therapeutics, Inc. (DE) (AZR)President and CEO买入524,954$0
2026-11-04Azora Therapeutics, Inc. (DE) (AZR)President and CEO买入101,298$0
2026-10-30ADIAL PHARMACEUTICALS, INC. (ADIL)President and CEO买入232,417$0
2026-06-16ADIAL PHARMACEUTICALS, INC. (ADIL)Chief Development Officer买入61,647$0
2026-06-16ADIAL PHARMACEUTICALS, INC. (ADIL)Chief Development Officer买入3,427$0
2026-06-16ADIAL PHARMACEUTICALS, INC. (ADIL)Chief Development Officer买入232,417$0
2026-06-16ADIAL PHARMACEUTICALS, INC. (ADIL)Chief Development Officer买入1,822$0
2026-06-16ADIAL PHARMACEUTICALS, INC. (ADIL)Chief Development Officer买入101$0

来源:SEC Form 4 申报文件 · 截至 2026-11-04